Deferred Tax Assets, Net of Valuation Allowance in USD of CVS HEALTH Corp from Q4 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
CVS HEALTH Corp quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2010 to Q4 2024.
  • CVS HEALTH Corp Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2024 was $7.61B, a 4.94% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)

CVS HEALTH Corp Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $7.61B -$395M -4.94% Dec 31, 2024 10-K 2025-02-12
Q4 2023 $8B +$17M +0.21% Dec 31, 2023 10-K 2025-02-12
Q4 2022 $7.99B +$327M +4.27% Dec 31, 2022 10-K 2024-02-07
Q4 2021 $7.66B -$116M -1.49% Dec 31, 2021 8-K 2023-05-25
Q4 2020 $7.77B +$465M +6.36% Dec 31, 2020 10-K 2022-02-09
Q4 2019 $7.31B +$5.56B +317% Dec 31, 2019 10-K 2021-02-16
Q4 2018 $1.75B +$824M +88.6% Dec 31, 2018 10-K 2020-02-18
Q4 2017 $930M Dec 31, 2017 8-K 2019-08-08
Q4 2010 $1.16B Dec 31, 2010 10-K 2011-02-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.